Comparison of Oxidant and Antioxidant Parameters in Patients with Sjögren’s Syndrome and Healthy Subjects
暂无分享,去创建一个
O. Erel | S. Neşelioğlu | M. Ergin | Ş. Erten | I. Dogan | A. Şahin | S. Işıkoğlu
[1] K. Tsubota,et al. Potential Role of Oxidative Stress in Ocular Surface Inflammation and Dry Eye Disease. , 2018, Investigative ophthalmology & visual science.
[2] M. Whiteman,et al. Oxidative stress in autoimmune rheumatic diseases , 2018, Free radical biology & medicine.
[3] M. O’Brien,et al. Oxidative T Cell Modifications in Lupus and Sjogren’s Syndrome , 2017, Lupus.
[4] S. Neşelioğlu,et al. Comparison of serum oxidant and antioxidant parameters in familial Mediterranean fever patients (FMF) with attack free period. , 2014, Acta reumatologica portuguesa.
[5] A. Tvarijonaviciute,et al. Serum paraoxonase 1 (PON1) measurement: an update , 2014, BMC Veterinary Research.
[6] F. Pallardó,et al. Sjøgren's syndrome-associated oxidative stress and mitochondrial dysfunction: Prospects for chemoprevention trials , 2013, Free radical research.
[7] G. Paragh,et al. Decreased human paraoxonase-1 activity in patients with Sjögren's syndrome. , 2010, International immunology.
[8] A. Vissink,et al. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. , 2010, Arthritis and rheumatism.
[9] A. Kızıltunç,et al. Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients , 2010, Clinics.
[10] H. Çelik,et al. Oxidative imbalance in bipolar disorder subtypes: A comparative study , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[11] F. Akçay,et al. Serum lipid profile paraoxonase and arylesterase activities in psoriasis , 2009, Cell biochemistry and function.
[12] S. Erdinç,et al. Baseline and salt‐stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity , 2009, Internal medicine journal.
[13] M. Rabus,et al. Plasma and tissue oxidative stress index in patients with rheumatic and degenerative heart valve disease. , 2008, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[14] G. Paragh,et al. Reduced Paraoxonase1 Activity Is a Risk for Atherosclerosis in Patients with Systemic Lupus Erythematosus , 2007, Annals of the New York Academy of Sciences.
[15] R. Browne,et al. Accuracy and biological variation of human serum paraoxonase 1 activity and polymorphism (Q192R) by kinetic enzyme assay. , 2007, Clinical chemistry.
[16] A. Işık,et al. Paraoxonase and arylesterase levels in rheumatoid arthritis , 2007, Clinical Rheumatology.
[17] A. Koçyiğit,et al. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. , 2005, Clinical biochemistry.
[18] O. Erel,et al. Measurement of the total antioxidant response in preeclampsia with a novel automated method. , 2005, European journal of obstetrics, gynecology, and reproductive biology.
[19] S. Karakucuk,et al. Serum paraoxonase activity is decreased in the active stage of Behçet’s disease , 2004, British Journal of Ophthalmology.
[20] O. Erel,et al. A novel automated method to measure total antioxidant response against potent free radical reactions. , 2004, Clinical biochemistry.
[21] Y. Ikeda,et al. Serum paraoxonase activity decreases in rheumatoid arthritis. , 2003, Life sciences.
[22] D. Isenberg,et al. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. , 2002, Arthritis and rheumatism.
[23] R. Jonsson,et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.
[24] D. Isenberg,et al. Myositis and swollen knees: disease or treatment complication? , 2002, Annals of the rheumatic diseases.
[25] L. Bn,et al. The polymorphic paraoxonase/arylesterase isozymes of human serum. , 1984 .
[26] B. La Du,et al. The polymorphic paraoxonase/arylesterase isozymes of human serum. , 1984, Federation proceedings.
[27] B. La Du,et al. The human serum paraoxonase/arylesterase polymorphism. , 1983, American journal of human genetics.